An innovative, competitively funded 3 year PhD programme has been established between the University of Cambridge and MedImmune. The programme will provide the opportunity to work at the interface of academia and industry with successful applicants undertaking a significant proportion of their research at both the University of Cambridge and at MedImmune. The programme aims to promote pre-clinical innovative translational research and to strengthen understanding of disease.
About MedImmune: MedImmune, the global biologics unit of AstraZeneca, is committed to developing better medicines that help people live healthier, longer and more satisfying lives. The company is focused on the areas of cardiovascular and metabolic disease, infection, respiratory and inflammatory disease, oncology and neuroscience, with two marketed products and a robust pipeline of promising new product candidates. MedImmune's state-of-the-art Cambridge site is home to around 600 employees, and serves as the company's European hub for research and development.
Project Details: An unbiased proteomic approach to identifying cell surface markers in neutrophils
Applications are invited for the Autumn 2017 intake for the following PhD studentship in the field of cellular immunology and proteomics. This studentship will be split between the Department of Medicine/CIMR in the University of Cambridge and MedImmune where we envisage the student will split their time between sites as experiments demand it and to make the best use of the world class resources available.
For this studentship we are looking for candidates with an actual or anticipated 1st or 2i Class degree in a relevant undergraduate subject (e.g. Biological Sciences, Biochemistry, Immunology etc). Additional qualifications/experience (e.g. at MSc/MPhil level) in a cognate area would be an advantage but not essential.
Applicants are encouraged to contact the Cambridge Supervisors informally for further information about the project.
Professor PJ Lehner and Professor ER Chilvers (firstname.lastname@example.org ), Department of Medicine, University of Cambridge.
Dr D Finch, Respiratory, Inflammation and Autoimmunity, MedImmune Ltd., Cambridge
How to Apply: Please note that this project is open to UK/EU applicants only.
Applications should be made on-line via the Cambridge Graduate Admissions Office applicant portal www.graduate.study.cam.ac.uk/applicant-portal selecting course details MDMDMI22 MedImmune@Medicine.
Fixed-term: The funds for this post are available for 3 years in the first instance.
The closing date for applications is the 14th March 2017. Interviews are likely to take place between end March to mid-April 2017 with a date to be advised by the department.
Please quote reference RC11452 on your application and in any correspondence about this vacancy.
The University values diversity and is committed to equality of opportunity.
The University has a responsibility to ensure that all employees are eligible to live and work in the UK.
Ph D Studentship Trading Standards Impact On Economic Growth, Anglia Ruskin University, United Kingdom, 29 days ago
Lord Ashcroft International Business School (LAIBS): Our newly established Doctoral School provides a supportive research environment for over 900 postgraduate research students. We have a vibrant...